Page 25 - Use Listing News Today

Chinese companies to supply 110 mln COVID-19 vaccines immediately to COVAX project Chinese companies to supply 110 mln... Gavi announced in a press release that it had signed advance purchase agreements with Sinopharm for its "BBIBP-CorV" inactivated virus vaccine and with Sinovac for its inactivated virus vaccine "CoronaVac". Two Chinese pharmaceutical companies will provide 110 million doses of COVID-19 vaccines immediately to participants of the COVAX project, announced the global Vaccine Al...

Delta variant ripping around the world at a scorching pace, driving new spike in cases, death: WHO SECTIONS Delta variant ripping around the world at a scorching pace, driving new spike in cases, death: WHOPTI Last Updated: Jul 13, 2021, 09:00 AM IST Share Synopsis In countries with low vaccine coverage, the situation is “particularly bad”, he warned, stressing that Delta and other highly transmissible variants are driving catastrophic waves of case, which are translating into high numbers ...

Delta variant ripping around the world at a scorching pace, driving new spike in deaths: WHO Agencies July 13, 2021 The Delta variant is ripping around the world at a scorching pace, driving a new spike in cases and deaths, WHO chief Tedros Adhanom Ghebreyesus has said, warning that the variant, now in over 104 countries, is expected to soon be the dominant Covid-19 strain circulating worldwide. Addressing a press briefing on Monday, he said that last week marked the fourth consecutive week of ...

Delta Variant Driving Covid Fatalities, Will Soon Become Dominant Global Strain: WHO ‘The Delta variant is ripping around the world at a scorching pace, driving a new spike in cases and death. Delta is now in more than 104 countries,’ WHO chief Tedros Adhanom Ghebreyesus said Outlook Web Bureau 13 July 2021, Last Updated at 9:33 am AP Photo Outlook Web Bureau 2021-07-13T09:29:58+05:30 Delta Variant Driving Covid Fatalities, Will Soon Become Dominant Global...

KUALA LUMPUR: Anyone who has received full doses of Covid-19 vaccines authorised by member countries are allowed entry, says the European Union (EU). The clarification came following reports that the EU Digital Covid Certificate only recognised vaccines approved by the bloc. It added that member states have also lifted travel restrictions on those who received Covid-19 vaccines that are yet to be approved by the EU, as long as the manufacturers have gone through the World Health Organisation’...

COVAX urges equal recognition of all COVID-19 vaccines COVAX was built on the principle of equitable access to COVID-19 vaccines to protect the health of people all across the globe. That means protecting their lives and livelihoods, including their ability to travel and conduct trade. As travel and other possibilities begin to open up in some parts of the world, COVAX urges all regional, national and local government authorities to recognize as fully vaccinated all people who have received COV...

Covaxin third phase clinical trials results out, 77.8 per cent effective against Covid-19 Covaxin has also been found to be 65.2 percent effective against the dreaded Delta variant of Coronavirus, which is becoming the dominant strain of the virus across the world.  Share Via Email   |  A+A A- By Express News Service HYDERABAD: Covaxin, the Covid-19 vaccine developed by Hyderabad-based vaccine maker Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), ha...

Final Phase-3 results of Covaxin show efficacy of 77.8% against Covid ​ By IANS | ​ 93 Views Final Phase-3 results of Covaxin show efficacy of 77.8% against Covid. Image Source: IANS News New Delhi, July 3 : Efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic COVID-19, through evaluation of 130 confirmed cases, with 24 observed in the vaccine group versus 106 in the placebo group. Bharat Biotech has concluded final analysis for Covaxin efficacy from Ph...

Covaxin Phase 3 Trial Result: 65.2% Efficacy Against Delta Variant, 77.8% Against Symptomatic COVID-19 Infection Covaxin, Indias indigenous COVID-19 vaccine, has concluded its final phase 3 trials and the results are out. Read on to know all about it. Written by Jahnavi Sarma | Published : July 3, 2021 12:19 PM IST Bharat Biotech has announced the safety and efficacy analysis data from Phase 3 clinical trials of Covaxin, its whole virion inactivated vaccine against SARS-CoV2, developed in partn...

COVAX calls for equal recognition of COVID-19 vaccines ANI | Updated: Jul 02, 2021 07:38 IST New York [US], July 2 (ANI): COVAX, the global alliance for vaccine distribution, on Thursday urged governments around the world to recognize as fully vaccinated all people who have received COVID-19 vaccines that have been deemed safe and effective by the World Health Organization (WHO). COVAX in a statement said it was built on the principle of equitable access to...